C.I. Medical Co.,Ltd. (TYO:3540)
Japan
· Delayed Price · Currency is JPY 898.00
-5.00 (-0.55%)
May 23, 2025, 3:30 PM JST
C.I. Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | - | 7,078 | 3,184 | 3,851 | 4,285 | 4,450 | Upgrade
|
| Depreciation & Amortization | - | 2,336 | 1,022 | 396 | 345 | 271 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 32 | - | - | 26 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 51 | 60 | 37 | 105 | 322 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -19 | -51 | - | - | - | Upgrade
|
| Other Operating Activities | - | -966 | -1,389 | -1,146 | -2,244 | -710 | Upgrade
|
| Change in Accounts Receivable | - | -745 | -224 | -378 | 53 | -814 | Upgrade
|
| Change in Inventory | - | 417 | -1,355 | -1,079 | -632 | -143 | Upgrade
|
| Change in Accounts Payable | - | 64 | -8 | 214 | -121 | 572 | Upgrade
|
| Change in Other Net Operating Assets | - | -2,095 | -1,395 | -486 | -239 | 211 | Upgrade
|
| Operating Cash Flow | - | 6,153 | -156 | 1,409 | 1,578 | 4,159 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -10.71% | -62.06% | 196.65% | Upgrade
|
| Capital Expenditures | - | -1,224 | -8,930 | -9,348 | -2,831 | -458 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 125 | 10 | 9 | - | - | Upgrade
|
| Cash Acquisitions | - | -2,855 | -814 | -705 | -45 | -205 | Upgrade
|
| Investment in Securities | - | -156 | -73 | -7 | 4 | -29 | Upgrade
|
| Other Investing Activities | - | 5 | 12 | 2 | 8 | -2 | Upgrade
|
| Investing Cash Flow | - | -4,105 | -9,795 | -10,049 | -3,051 | -764 | Upgrade
|
| Short-Term Debt Issued | - | 758 | 10,100 | 7,000 | - | - | Upgrade
|
| Total Debt Issued | - | 758 | 10,100 | 7,000 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 758 | 10,100 | 7,000 | - | - | Upgrade
|
| Dividends Paid | - | -252 | -252 | -282 | -584 | -150 | Upgrade
|
| Other Financing Activities | - | -130 | -23 | -8 | - | - | Upgrade
|
| Financing Cash Flow | - | 376 | 9,825 | 6,710 | -584 | -150 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 1 | 76 | 10 | 26 | -14 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 17 | 2 | 1 | -1 | Upgrade
|
| Net Cash Flow | - | 2,425 | -33 | -1,918 | -2,030 | 3,230 | Upgrade
|
| Free Cash Flow | - | 4,929 | -9,086 | -7,939 | -1,253 | 3,701 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 223.51% | Upgrade
|
| Free Cash Flow Margin | - | 7.30% | -19.91% | -18.51% | -3.04% | 9.90% | Upgrade
|
| Free Cash Flow Per Share | - | 98.58 | -181.74 | -158.80 | -25.06 | 74.02 | Upgrade
|
| Cash Interest Paid | - | 68 | 18 | 6 | - | - | Upgrade
|
| Cash Income Tax Paid | - | 949 | 1,370 | 1,139 | 2,229 | 708 | Upgrade
|
| Levered Free Cash Flow | - | 2,463 | -10,494 | -7,067 | -1,460 | 3,523 | Upgrade
|
| Unlevered Free Cash Flow | - | 2,501 | -10,484 | -7,067 | -1,460 | 3,523 | Upgrade
|
| Change in Net Working Capital | 202 | 170 | 4,445 | 610 | 1,801 | -771 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.